IPO Trending
GLHRLSME / BSEListed
Global Longlife Hospital and Research

Global Longlife Hospital and Research Limited is an NABH-accredited multi-speciality tertiary care hospital based in Ahmedabad, Gujarat, offering a wide range of healthcare services including oncology, ophthalmology, cardiology, dermatology, gynecology, spine and plastic surgery, dialysis, physiotherapy, ultrasound, and microbiology. The hospital has a capacity of 110 well-equipped beds supporting both medical and surgical specialties, and as of December 31, 2021, it is supported by 11 full-time consultants, over 30 experienced consulting doctors, 37 nurses, and more than 50 paramedical, pharmacy, corporate, and support staff, ensuring comprehensive and quality patient care.

₹140 - ₹140Open
Listed Price₹141.10
Listing Gain+0.79%

Subscription Status

0Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date21 Apr 2022
Close Date25 Apr 2022
Listing Date04 May 2022
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Global Longlife Hospital and Research IPO Subscription Demand

Live subscription status and bidding analysis for Global Longlife Hospital and Research (GLHRL) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions